Actively targeted chitosan-based vector for efficient CRISPR-Cas9 mediated Tenascin-C gene editing in triple negative breast cancer

Basit Öğe Kaydı
dc.authoridŞALVA, EMINE/0000-0002-1159-5850
dc.authoridOladipo, Akeem Adeyemi/0000-0003-3715-5922
dc.authorwosidŞALVA, EMINE/CAH-3062-2022
dc.authorwosidOladipo, Akeem Adeyemi/J-4664-2015
dc.contributor.authorBareke, H.
dc.contributor.authorFuentes, M.
dc.contributor.authorOladipo, A. A.
dc.contributor.authorOzbas, S.
dc.contributor.authorSalva, E.
dc.date.accessioned2024-08-04T20:56:22Z
dc.date.available2024-08-04T20:56:22Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.descriptionESGCT Collaborative Virtual Congress -- OCT 19-22, 2021 -- ELECTR NETWORKen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipESGCT,Hellen Soc Gene Therapy & Regenerat Med,ISGCT,NVGCT,SETGC,SFTCG,British Soc Gene & Cell Therapyen_US
dc.description.sponsorshipInonu University, Department of Scientific Research Projects [TOA-2019-1543]en_US
dc.description.sponsorshipThe research was funded by Inonu University, Department of Scientific Research Projects (TOA-2019-1543).en_US
dc.identifier.endpageA36en_US
dc.identifier.issn1043-0342
dc.identifier.issn1557-7422
dc.identifier.issue19-20en_US
dc.identifier.startpageA36en_US
dc.identifier.urihttps://hdl.handle.net/11616/102269
dc.identifier.volume32en_US
dc.identifier.wosWOS:000811305600100en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherMary Ann Liebert, Incen_US
dc.relation.ispartofHuman Gene Therapyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleActively targeted chitosan-based vector for efficient CRISPR-Cas9 mediated Tenascin-C gene editing in triple negative breast canceren_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu